Response by Omland et al to Letter Regarding Article, “Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial”

Torbjørn Omland; Siri Lagethon Heck; Espen Holte; Mari Nordbø Gynnild; Geeta Gulati; Torgeir Wethal

doi:10.1161/circulationaha.126.079810

Response by Omland et al to Letter Regarding Article, “Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial”

T Torbjørn Omland (K.G. Jebsen Centre for Cardiac Biomarkers, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway (T.O., S.L.H., M.N.G., G.G.).) S Siri Lagethon Heck (K.G. Jebsen Centre for Cardiac Biomarkers, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway (T.O., S.L.H., M.N.G., G.G.).) E Espen Holte M Mari Nordbø Gynnild (K.G. Jebsen Centre for Cardiac Biomarkers, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway (T.O., S.L.H., M.N.G., G.G.).) G Geeta Gulati (K.G. Jebsen Centre for Cardiac Biomarkers, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway (T.O., S.L.H., M.N.G., G.G.).) T Torgeir Wethal

View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Circulation

Volume / Issue Vol. 153, Issue 22

Published June 02, 2026

DOI 10.1161/circulationaha.126.079810

ISSN 0009-7322

Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (6)

T

Torbjørn Omland

K.G. Jebsen Centre for Cardiac Biomarkers, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway (T.O., S.L.H., M.N.G., G.G.).

S

Siri Lagethon Heck

K.G. Jebsen Centre for Cardiac Biomarkers, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway (T.O., S.L.H., M.N.G., G.G.).

E

Espen Holte

M

Mari Nordbø Gynnild

K.G. Jebsen Centre for Cardiac Biomarkers, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway (T.O., S.L.H., M.N.G., G.G.).

G

Geeta Gulati

K.G. Jebsen Centre for Cardiac Biomarkers, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway (T.O., S.L.H., M.N.G., G.G.).

T

Torgeir Wethal

Response by Omland et al to Letter Regarding Article, “Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial”

Article Details

Journal Info

Authors (6)

Related Articles from this Journal

Occupational Radiation Safety in Electrophysiology During Pregnancy: Evaluating Uterine Radiation Doses During Catheter Ablations and Device Implantations

Response by Rogers et al to Letter Regarding, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”

Clinical Cardiology at the Crossroads: Perspectives on the Next Era at <i>Circulation</i>

ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction

Letter by Li et al Regarding Article, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”